CVS Health Corporation (CVS.DE) • XETRA
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold CVS.DE in your mock portfolio yet.
The provided fundamentals (P/E of 44.93 and EPS of 1.99) imply a rich valuation relative to current earnings, suggesting the market is pricing in a meaningful earnings recovery or growth. Without full income-statement detail, the high P/E versus modest EPS points to either depressed current earnings or elevated expectations, which introduces execution risk. Overall, the financial picture implied here is balanced between recovery potential and valuation risk.
The stock’s 10.4% gain over the last month and its current price significantly above the 200-day moving average indicate strong positive momentum. Trading at €89.42 versus a 200-day moving average of €69.03 suggests a well-established uptrend, though it may also be somewhat extended in the near term. Absent an overbought RSI reading, the technical setup leans bullish but susceptible to pullbacks after a sharp run.
Alternative data for CVS Health Corporation is broadly constructive: web traffic is high, app downloads are very strong despite a slight month-over-month decline, and job openings are growing, which often reflects expansion or investment in operations. Social media presence is large and generally growing across most platforms, indicating stable or improving brand engagement. Overall, these signals point to healthy customer interaction and organizational growth, supportive of a positive medium-term outlook.
CVS Health Corporation’s stock currently exhibits strong technical momentum and supportive alternative data, but this is offset by a high earnings multiple and limited visibility into near-term profitability improvements. The balance of elevated valuation against positive operational and engagement signals leads to an overall neutral stance, with upside potential contingent on delivering the earnings growth implied by the current price. Investors may view the name as attractive on pullbacks if fundamental progress continues to validate the premium multiple.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Upgrade to see the full Evidence Stack
What Changed, Why Now, and Risk Flags — available on the Investor plan and above
Get Started